Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA
Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )
18 Jun 2012

Novel PET tracers and their future use in assessment of response to treatment

Dr Andrei Iagaru – Stanford University, CA, USA
Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )
17 Jun 2012

Treating metastatic melanoma with vemurafenib

Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA
Treating metastatic melanoma with vemurafenib ( Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA
Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jun 2012

Role of family history and genetic testing in diagnosis

Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012

First line treatment against metastatic breast cancer

Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada
First line treatment against metastatic breast cancer ( Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada )
15 Jun 2012

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Dr Sagar Lonial – Emory University, Atlanta, USA
Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma ( Dr Sagar Lonial – Emory University, Atlanta, USA )
15 Jun 2012

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA
Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )
15 Jun 2012

Decision making in surgical breast cancer treatment

Dr Monica Morrow – Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Decision making in surgical breast cancer treatment ( Dr Monica Morrow – Memorial Sloan-Kettering Cancer Center, New York, NY, USA )
15 Jun 2012

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA
President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )
4 Jun 2012

New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma

Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany
New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma ( Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany )
4 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation